USD 10.0
(19.47%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.98 SGD | 46.27% |
2022 | 0.67 SGD | 34.0% |
2021 | 0.50 SGD | -7.41% |
2020 | 0.54 SGD | -34.15% |
2019 | 0.82 SGD | 1.23% |
2018 | 0.81 SGD | 44.64% |
2017 | 0.56 SGD | -1.75% |
2016 | 0.57 SGD | -32.14% |
2015 | 0.84 SGD | 55.56% |
2014 | 0.54 SGD | 10.2% |
2013 | 0.49 SGD | -10.91% |
2012 | 0.55 SGD | 48.65% |
2011 | 0.37 SGD | -28.85% |
2010 | 0.52 SGD | 100.0% |
2009 | 0.26 SGD | -27.78% |
2008 | 0.36 SGD | -49.3% |
2007 | 0.71 SGD | 51.06% |
2006 | 0.47 SGD | 0.0% |
2005 | - SGD | 0.0% |
2004 | - SGD | 0.0% |
2003 | - SGD | -100.0% |
2002 | 0.08 SGD | -46.07% |
2001 | 0.15 SGD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.28 SGD | 0.0% |
2024 Q1 | 0.28 SGD | 12.0% |
2023 Q2 | 0.24 SGD | 0.0% |
2023 FY | - SGD | 46.27% |
2023 Q4 | 0.25 SGD | 0.0% |
2023 Q1 | 0.24 SGD | 50.0% |
2023 Q3 | 0.25 SGD | 4.17% |
2022 Q1 | 0.17 SGD | -34.62% |
2022 FY | - SGD | 34.0% |
2022 Q2 | 0.35 SGD | 105.88% |
2022 Q4 | 0.16 SGD | 0.0% |
2022 Q3 | 0.16 SGD | -54.29% |
2021 Q3 | 0.13 SGD | -45.83% |
2021 Q2 | 0.24 SGD | 100.0% |
2021 FY | - SGD | -7.41% |
2021 Q1 | 0.12 SGD | -7.69% |
2021 Q4 | 0.26 SGD | 100.0% |
2020 Q3 | 0.07 SGD | -84.1% |
2020 Q1 | 0.21 SGD | 260.21% |
2020 Q2 | 0.41 SGD | 95.24% |
2020 Q4 | 0.13 SGD | 99.39% |
2020 FY | - SGD | -34.15% |
2019 Q4 | 0.06 SGD | -77.58% |
2019 Q3 | 0.26 SGD | -36.59% |
2019 Q2 | 0.41 SGD | 310.0% |
2019 Q1 | 0.10 SGD | 7.99% |
2019 FY | - SGD | 1.23% |
2018 Q3 | 0.26 SGD | -29.73% |
2018 FY | - SGD | 44.64% |
2018 Q2 | 0.37 SGD | 320.45% |
2018 Q1 | 0.09 SGD | 33.13% |
2018 Q4 | 0.09 SGD | -64.38% |
2017 Q2 | 0.23 SGD | 202.63% |
2017 FY | - SGD | -1.75% |
2017 Q4 | 0.07 SGD | -63.28% |
2017 Q3 | 0.18 SGD | -21.74% |
2017 Q1 | 0.08 SGD | -16.94% |
2016 FY | - SGD | -32.14% |
2016 Q4 | 0.09 SGD | -51.84% |
2016 Q3 | 0.19 SGD | -13.64% |
2016 Q2 | 0.22 SGD | 238.46% |
2016 Q1 | 0.06 SGD | -25.03% |
2015 Q2 | 0.53 SGD | 768.85% |
2015 FY | - SGD | 55.56% |
2015 Q3 | 0.16 SGD | -69.81% |
2015 Q4 | 0.09 SGD | -45.81% |
2015 Q1 | 0.06 SGD | -27.21% |
2014 FY | - SGD | 10.2% |
2014 Q1 | 0.06 SGD | -49.09% |
2014 Q4 | 0.08 SGD | -30.17% |
2014 Q3 | 0.12 SGD | -57.14% |
2014 Q2 | 0.28 SGD | 400.0% |
2013 Q1 | 0.04 SGD | 0.0% |
2013 FY | - SGD | -10.91% |
2013 Q4 | 0.11 SGD | 10.0% |
2013 Q3 | 0.10 SGD | -60.0% |
2013 Q2 | 0.25 SGD | 614.29% |
2012 Q4 | - SGD | -100.0% |
2012 FY | - SGD | 48.65% |
2012 Q1 | 0.03 SGD | 0.0% |
2012 Q2 | 0.20 SGD | 495.24% |
2012 Q3 | 0.09 SGD | -53.0% |
2011 FY | - SGD | -28.85% |
2011 Q1 | 0.03 SGD | 0.0% |
2011 Q2 | 0.24 SGD | 700.0% |
2011 Q4 | - SGD | -100.0% |
2011 Q3 | 0.03 SGD | -85.63% |
2010 Q1 | 0.03 SGD | 0.0% |
2010 FY | - SGD | 100.0% |
2010 Q4 | - SGD | -100.0% |
2010 Q3 | 0.14 SGD | -36.36% |
2010 Q2 | 0.22 SGD | 554.76% |
2009 FY | - SGD | -27.78% |
2009 Q3 | 0.10 SGD | -50.0% |
2009 Q2 | 0.20 SGD | 378.47% |
2009 Q1 | 0.04 SGD | 0.0% |
2009 Q4 | - SGD | -100.0% |
2008 FY | - SGD | -49.3% |
2007 FY | - SGD | 51.06% |
2006 FY | - SGD | 0.0% |
2005 FY | - SGD | 0.0% |
2004 FY | - SGD | 0.0% |
2003 FY | - SGD | -100.0% |
2002 Q4 | -0.02 SGD | 0.0% |
2002 Q2 | 0.10 SGD | 0.0% |
2002 FY | - SGD | -46.07% |
2001 FY | - SGD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AstraZeneca PLC | 3.84 USD | 74.479% |
Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | 74.742% |
CSPC Pharmaceutical Group Limited | 0.07 USD | -1300.0% |
Clarus Therapeutics Holdings, Inc. | -8.04 USD | 112.189% |
Novartis AG | 7.63 USD | 87.156% |
PT Kalbe Farma Tbk. | 0.00 USD | -25028.205% |